International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
The aim of this study was to construct the fourth in a series of guidelines on the treatment of urolithiasis by the International Alliance of Urolithiasis (IAU) that by providing a clinical framework for the metabolic evaluation, prevention, and follow-up of patients with urolithiasis based on the best available published literature. All recommendations were summarized following a systematic review and assessment of the literature in the PubMed database from January 1976 to June 2022. Each generated recommendation was graded using a modified GRADE methodology. Guideline recommendations were developed that addressed the following topics: initial evaluation, metabolic testing, dietary measures, medical management, and follow-up of recurrent stone formers. It was emphasized by the Panel that prevention of new stone formation is as important as the surgical removal of the stones. Although general preventive measures may be effective in reducing stone recurrence rates in some patients, specific medical and dietary management should be well considered and eventually applied in an individualized manner based on the outcomes of metabolic work-up, stone analysis and some certain patient related factors. A detailed follow-up of each case is essential depending on the metabolic activity of each individual patient.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
|---|---|
| Enthalten in: |
Urolithiasis - 51(2022), 1 vom: 01. Dez., Seite 4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zeng, Guohua [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Follow-up |
|---|
| Anmerkungen: |
Date Completed 05.12.2022 Date Revised 05.12.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00240-022-01387-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349669759 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349669759 | ||
| 003 | DE-627 | ||
| 005 | 20231226043159.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00240-022-01387-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1165.xml |
| 035 | |a (DE-627)NLM349669759 | ||
| 035 | |a (NLM)36454329 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zeng, Guohua |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a International Alliance of Urolithiasis (IAU) guidelines on the metabolic evaluation and medical management of urolithiasis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.12.2022 | ||
| 500 | |a Date Revised 05.12.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a The aim of this study was to construct the fourth in a series of guidelines on the treatment of urolithiasis by the International Alliance of Urolithiasis (IAU) that by providing a clinical framework for the metabolic evaluation, prevention, and follow-up of patients with urolithiasis based on the best available published literature. All recommendations were summarized following a systematic review and assessment of the literature in the PubMed database from January 1976 to June 2022. Each generated recommendation was graded using a modified GRADE methodology. Guideline recommendations were developed that addressed the following topics: initial evaluation, metabolic testing, dietary measures, medical management, and follow-up of recurrent stone formers. It was emphasized by the Panel that prevention of new stone formation is as important as the surgical removal of the stones. Although general preventive measures may be effective in reducing stone recurrence rates in some patients, specific medical and dietary management should be well considered and eventually applied in an individualized manner based on the outcomes of metabolic work-up, stone analysis and some certain patient related factors. A detailed follow-up of each case is essential depending on the metabolic activity of each individual patient | ||
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Follow-up | |
| 650 | 4 | |a IAU | |
| 650 | 4 | |a Kidney stone | |
| 650 | 4 | |a Metabolic evaluation | |
| 650 | 4 | |a Prevention | |
| 650 | 4 | |a Urolithiasis | |
| 700 | 1 | |a Zhu, Wei |e verfasserin |4 aut | |
| 700 | 1 | |a Robertson, William G |e verfasserin |4 aut | |
| 700 | 1 | |a Penniston, Kristina L |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Daron |e verfasserin |4 aut | |
| 700 | 1 | |a Pozdzik, Agnieszka |e verfasserin |4 aut | |
| 700 | 1 | |a Tefik, Tzevat |e verfasserin |4 aut | |
| 700 | 1 | |a Prezioso, Domenico |e verfasserin |4 aut | |
| 700 | 1 | |a Pearle, Margaret S |e verfasserin |4 aut | |
| 700 | 1 | |a Chew, Ben H |e verfasserin |4 aut | |
| 700 | 1 | |a Veser, Julian |e verfasserin |4 aut | |
| 700 | 1 | |a Fiori, Cristian |e verfasserin |4 aut | |
| 700 | 1 | |a Deng, Yaoliang |e verfasserin |4 aut | |
| 700 | 1 | |a Straub, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Türk, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Semins, Michelle J |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Kunjie |e verfasserin |4 aut | |
| 700 | 1 | |a Marangella, Martino |e verfasserin |4 aut | |
| 700 | 1 | |a Jia, Zhankui |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Liyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Ye, Zhangqun |e verfasserin |4 aut | |
| 700 | 1 | |a Tiselius, Hans-Göran |e verfasserin |4 aut | |
| 700 | 1 | |a Sarica, Kemal |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Urolithiasis |d 2013 |g 51(2022), 1 vom: 01. Dez., Seite 4 |w (DE-627)NLM225275902 |x 2194-7236 |7 nnns |
| 773 | 1 | 8 | |g volume:51 |g year:2022 |g number:1 |g day:01 |g month:12 |g pages:4 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00240-022-01387-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 51 |j 2022 |e 1 |b 01 |c 12 |h 4 | ||